Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen W Reese

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Urology|July 7, 2023
Reply by AuthorsStephen W Reese, Sari Khaleel, Andrew Silagy, et al.
The Journal of Urology|May 11, 2023
Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive NephrectomyStephen W Reese, Sari Khaleel, Andrew Silagy, et al.
Urology Practice|June 24, 2024
Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal DiseaseLennert Eismann, Mark Zucker, Mark T Dawidek, et al.
Investigative and Clinical Urology|December 14, 2020
Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeismMarieke J Krimphove, Stephen W Reese, Xi Chen, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
Urologic Oncology|September 6, 2025
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinomaStephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
Urologic Oncology|December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinomaStephen W Reese, Lennert Eismann, Charlie White, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Urology|July 7, 2023
Reply by AuthorsStephen W Reese, Sari Khaleel, Andrew Silagy, et al.
The Journal of Urology|May 11, 2023
Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive NephrectomyStephen W Reese, Sari Khaleel, Andrew Silagy, et al.
Urology Practice|June 24, 2024
Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal DiseaseLennert Eismann, Mark Zucker, Mark T Dawidek, et al.
Investigative and Clinical Urology|December 14, 2020
Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeismMarieke J Krimphove, Stephen W Reese, Xi Chen, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
Urologic Oncology|September 6, 2025
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinomaStephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, et al.
Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.
Urologic Oncology|December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinomaStephen W Reese, Lennert Eismann, Charlie White, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Pageof 3